The Global Pregabalin market was valued at US$ 828.56 Mn. in 2023, and it is expected to reach US$ 1067.78 Mn. by 2030 with a CAGR of 3.69% during the forecast period. Pregabalin is an anticonvulsant and anxiolytic drug that is used to treat a variety of disorders, including epilepsy, neuropathic pain, fibromyalgia, restless leg syndrome, and generalised anxiety disorder. https://www.maximizemarketresearch.com/market-report/global-pregabalin-market/109027/